4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-21-000120
President and CEO acquired 27,200 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Brunn Carsten President and CEO | 2021-09-24 | Grant or award | +27,200 | 256,572 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Brunn Carsten President and CEO | 2021-09-24 | Grant or award · Employee Stock Option (right to buy) | +163,000 | 163,000 | D: show line 2 in the form |
Loading xslF345X03/wf-form4_163286110389016.xml…